Farzin Haque
Stock Analyst at Jefferies
(2.92)
# 1,374
Out of 5,169 analysts
4
Total ratings
75%
Success rate
68.21%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Farzin Haque
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RLMD Relmada Therapeutics | Initiates: Buy | $9 | $6.45 | +39.53% | 1 | Dec 22, 2025 | |
| NUVB Nuvation Bio | Initiates: Buy | $10 | $4.40 | +127.27% | 1 | Sep 30, 2025 | |
| PYXS Pyxis Oncology | Assumes: Buy | $10 | $1.62 | +517.28% | 1 | May 7, 2024 | |
| VERA Vera Therapeutics | Upgrades: Buy | $18 → $26 | $39.32 | -33.88% | 1 | Nov 10, 2023 |
Relmada Therapeutics
Dec 22, 2025
Initiates: Buy
Price Target: $9
Current: $6.45
Upside: +39.53%
Nuvation Bio
Sep 30, 2025
Initiates: Buy
Price Target: $10
Current: $4.40
Upside: +127.27%
Pyxis Oncology
May 7, 2024
Assumes: Buy
Price Target: $10
Current: $1.62
Upside: +517.28%
Vera Therapeutics
Nov 10, 2023
Upgrades: Buy
Price Target: $18 → $26
Current: $39.32
Upside: -33.88%